| Dr Lauren H Theilen, MD | |
|
50 N Medical Dr Ste 2185, Salt Lake City, UT 84132 | |
| (801) 581-8425 | |
| Not Available |
| Full Name | Dr Lauren H Theilen |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 50 N Medical Dr Ste 2185, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174802250 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Specialty Services | 2961726831 | 75 |
News Archive
Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.
South Carolina's Medicaid director says his agency is on track to spend about $250 million less this fiscal year than allotted in the state budget. Director Tony Keck told a Senate panel on Wednesday the Department of Health and Human Services is projected to spend $6.2 billion in state and federal money (Adcox, 12/4).
A team of scientists from the United States has recently explored the prevalence and transmission dynamics of the B.1.1.7 variant (UK variant) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States. The study reveals that because of 35-45% increased transmissibility, B.1.1.7 may soon become the US's dominant variant. The study is currently available on the medRxiv* preprint server.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
› Verified 3 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.
South Carolina's Medicaid director says his agency is on track to spend about $250 million less this fiscal year than allotted in the state budget. Director Tony Keck told a Senate panel on Wednesday the Department of Health and Human Services is projected to spend $6.2 billion in state and federal money (Adcox, 12/4).
A team of scientists from the United States has recently explored the prevalence and transmission dynamics of the B.1.1.7 variant (UK variant) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States. The study reveals that because of 35-45% increased transmissibility, B.1.1.7 may soon become the US's dominant variant. The study is currently available on the medRxiv* preprint server.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
› Verified 3 days ago
| Entity Name | University Of Utah Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043614811 PECOS PAC ID: 2961726831 Enrollment ID: O20150123002141 |
News Archive
Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.
South Carolina's Medicaid director says his agency is on track to spend about $250 million less this fiscal year than allotted in the state budget. Director Tony Keck told a Senate panel on Wednesday the Department of Health and Human Services is projected to spend $6.2 billion in state and federal money (Adcox, 12/4).
A team of scientists from the United States has recently explored the prevalence and transmission dynamics of the B.1.1.7 variant (UK variant) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States. The study reveals that because of 35-45% increased transmissibility, B.1.1.7 may soon become the US's dominant variant. The study is currently available on the medRxiv* preprint server.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
› Verified 3 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.
South Carolina's Medicaid director says his agency is on track to spend about $250 million less this fiscal year than allotted in the state budget. Director Tony Keck told a Senate panel on Wednesday the Department of Health and Human Services is projected to spend $6.2 billion in state and federal money (Adcox, 12/4).
A team of scientists from the United States has recently explored the prevalence and transmission dynamics of the B.1.1.7 variant (UK variant) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States. The study reveals that because of 35-45% increased transmissibility, B.1.1.7 may soon become the US's dominant variant. The study is currently available on the medRxiv* preprint server.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lauren H Theilen, MD 30 N 1900 E Ste 2a200, Salt Lake City, UT 84132-0002 Ph: (801) 581-8425 | Dr Lauren H Theilen, MD 50 N Medical Dr Ste 2185, Salt Lake City, UT 84132 Ph: (801) 581-8425 |
News Archive
Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.
South Carolina's Medicaid director says his agency is on track to spend about $250 million less this fiscal year than allotted in the state budget. Director Tony Keck told a Senate panel on Wednesday the Department of Health and Human Services is projected to spend $6.2 billion in state and federal money (Adcox, 12/4).
A team of scientists from the United States has recently explored the prevalence and transmission dynamics of the B.1.1.7 variant (UK variant) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States. The study reveals that because of 35-45% increased transmissibility, B.1.1.7 may soon become the US's dominant variant. The study is currently available on the medRxiv* preprint server.
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
› Verified 3 days ago
Virginia Jean Homewood, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3336 S 4155 W, Ste 301, Salt Lake City, UT 84120 Phone: 801-964-3865 Fax: 801-964-3894 | |
Alexandra L. Woodcock, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2a200, Salt Lake City, UT 84132 Phone: 801-213-3716 | |
Lillian B. Boettcher, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132 Phone: 801-581-7647 | |
Patricia Bearnson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4465 S 900 E Ste 275, Salt Lake City, UT 84124 Phone: 801-272-6100 Fax: 801-272-6101 | |
Eric C Nielson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1220 East 3900 South, Suite 3e, Salt Lake City, UT 84124 Phone: 801-685-7188 Fax: 801-685-8116 | |
Susan T Horvath, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1140 E 3900 S Ste 400, Salt Lake City, UT 84124 Phone: 801-262-8666 Fax: 801-263-8821 | |
Carolyn Weaver Swenson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-213-2995 |